Congress of the European Academy of Neurology 2026
The 12th Congress of the European Academy of Neurology took place from 27 – 30th June 2026 in Geneva Switzerland.
The conference was presided over by Prof. Elena Moro, president of the EAN, who welcomed all delegates to the meeting in the beautiful surroundings of Geneva with views of the Alps and of lake Geneva.
Prof. Moro’s address at the Presidential Dinner of the EAN stressed the importance of national societies working together to confront and address the range of neurological illnesses. The Congress opened with a clear message: the future of neurology will be shaped not by individual efforts alone, but by a community working together across borders, disciplines and generations.
During her opening speech, Moro presented the EAN’s priorities for shaping the future of neurology across Europe, highlighting the Enhancing Neurology in Europe initiative and the associated Brussels Neurology Declaration, signed by president and delegates of national neurological societies. The EAN is advancing a common agenda focused on brain health for all, equal access to treatment and funding, improved prevention and care, a stronger neurological workforce, interventional neurology, research and innovation, and the responsible integration of new technologies and artificial intelligence.
These priorities are ambitious precisely because they cannot be achieved by one organisation, one country or one specialty alone. They depend on cooperation between national neurological societies, patient organisations, professional partners, policymakers, researchers and clinicians. The message was clear: progress in neurology requires everyone to be “in the same ship.”
Recognising Excellence, Celebrating Community
Outstanding contributions to neurology by distinguished members of the community were acknowledged with the presentation of Honorary Membership to Prof. Josep Dalmau and Prof. Pamela Shaw. These recognitions celebrated scientific excellence and long-standing dedication to the neurological community.
The meeting was attended by a number of consultants and registrars from Ireland with the EAN inviting the IICN to host a Neurohood booth at the conference. This presented IICN staff with the opportunity to meet delegates from other European Neurological Associations and also a number of Associations outside of the EAN including Brazil, Turkey and the United States. Initiatives including the Brain Health programme for schools are very interesting and it is hoped that this can be introduced in Ireland over the coming months.
Involvement in the conference is most encouraging and stimulates greater interaction between the IICN and the EAN.
